Arch Therapeutics, Inc.

Ownership Transactions Reported by 7 Insiders

Symbol
ARTH on OTC
Location
235 Walnut Street, Suite 6, Framingham, MA

There are no Buy or Sell transactions made by insiders since 9/17/2023

Arch Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James R. Sulat Director Sep 27, 2021
Terrence Norchi PRESIDENT AND CHIEF EXECUTIVE, Director Aug 31, 2023
Dan Yrigoyen Vice President, Sales Nov 10, 2022
Laurence Hicks Director Aug 31, 2023
Guy L. Fish Director Nov 10, 2022
Punit Dhillon Director Nov 10, 2022
Michael Abrams Chief Financial Officer Aug 31, 2023

Recent Insider Transactions by Companies or Individuals for Arch Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.